Escherichia coli EDL933 requires gluconeogenic nutrients to successfully colonize the intestines of streptomycin-treated mice precolonized with E. coli Nissle 1917

Infection and Immunity
Silvia A C SchinnerP S Cohen

Abstract

Escherichia coli MG1655, a K-12 strain, uses glycolytic nutrients exclusively to colonize the intestines of streptomycin-treated mice when it is the only E. coli strain present or when it is confronted with E. coli EDL933, an O157:H7 strain. In contrast, E. coli EDL933 uses glycolytic nutrients exclusively when it is the only E. coli strain in the intestine but switches in part to gluconeogenic nutrients when it colonizes mice precolonized with E. coli MG1655 (R. L. Miranda et al., Infect Immun 72:1666-1676, 2004, http://dx.doi.org/10.1128/IAI.72.3.1666-1676.2004). Recently, J. W. Njoroge et al. (mBio 3:e00280-12, 2012, http://dx.doi.org/10.1128/mBio.00280-12) reported that E. coli 86-24, an O157:H7 strain, activates the expression of virulence genes under gluconeogenic conditions, suggesting that colonization of the intestine with a probiotic E. coli strain that outcompetes O157:H7 strains for gluconeogenic nutrients could render them nonpathogenic. Here we report that E. coli Nissle 1917, a probiotic strain, uses both glycolytic and gluconeogenic nutrients to colonize the mouse intestine between 1 and 5 days postfeeding, appears to stop using gluconeogenic nutrients thereafter in a large, long-term colonization niche, but con...Continue Reading

References

Jan 1, 1992·Molecular & General Genetics : MGG·M NiersbachH J Hirsch
Jan 1, 1972·Molecular & General Genetics : MGG·F B HaugliA Jimenez
Jan 1, 1972·Molecular & General Genetics : MGG·R C Gethmann
Jul 1, 1995·Infection·G BlumJ Hacker
Sep 5, 1997·Science·F R BlattnerY Shao
Nov 5, 1997·Current Opinion in Structural Biology·B Henrissat, G Davies
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Feb 24, 2001·Nature·N T PernaF R Blattner
Dec 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·R A WelchF R Blattner
Aug 5, 2004·Journal of Bacteriology·Lubomir GrozdanovUlrich Dobrindt
Aug 14, 2010·International Journal of Medical Microbiology : IJMM·Chantal Le Bouguénec, Catherine Schouler
May 24, 2011·Trends in Microbiology·Laurence RohmerSamuel I Miller
Dec 30, 2011·Current Opinion in Microbiology·Christopher J Alteri, Harry L T Mobley
Jan 15, 2013·International Journal of Medical Microbiology : IJMM·Stefan A RundTobias A Oelschlaeger
Apr 16, 2014·Infection and Immunity·E A WaligoraS M Payne
Dec 1, 2004·EcoSal Plus·Tyrell ConwayPaul S Cohen

❮ Previous
Next ❯

Citations

Sep 12, 2015·Cell Host & Microbe·Elizabeth A Cameron, Vanessa Sperandio
Jul 18, 2015·Microbiology Spectrum·Tyrrell Conway, Paul S Cohen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.